C. Kleoudis

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Richard Furie, Brad H. Rovin, Frédéric Houssiau et al. · New England Journal of Medicine · 2020 · 973 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study

William Stohl, Andreas Schwarting, Masato Okada et al. · Arthritis & Rheumatology · 2017 · 417 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

Ronald van Vollenhoven, Michelle Petri, Ricard Cervera et al. · Annals of the Rheumatic Diseases · 2012 · 407 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease

William J. Sandborn, William J. Tremaine, Douglas C. Wolf et al. · Gastroenterology · 1999 · 239 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

Lynn R. Webster, Jan Peter Jansen, John F. Peppin et al. · Pain · 2008 · 144 citations

Medicine, Pharmacology, Pharmacotherapy +17